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Despite the detrimental effects of abdominal visceral fat on many 
cardiovascular and metabolic diseases, the relationship between abdominal 
visceral obesity and osteoporosis remains controversial. In the present 
study, we investigated the association between bone mass and abdominal 
fat estimated by echocardiographic epicardial fat thickness, which is a 
surrogate measure of abdominal visceral fat, anthropometric data, and 
regional fat mass (FM) measured by dual energy x-ray absorptiometry 
(DXA). A total of 1198 subjects (525 men, 460 premenopausal women, and 
213 postmenopausal women) were selected from the Healthy Twin Study, 
a nationwide Korean twin and family study. Epicardial fat thickness was 
measured on the free wall of the right ventricle at end-systole from the 
parasternal long axis views. Total FM, regional FM, lean mass (LM), and 
bone mineral content (BMC) were measured by DXA. We performed 
multiple linear regression analysis with two models to determine the 
association between abdominal visceral obesity and osteoporosis. Age and 
height were included as covariates in Model 1. Past medical history and 
behavioral factors were included in Model 2. Epicardial fat thickness was 
positively associated with BMC in all three subgroups (men, 
premenopausal women, and postmenopausal women) in Model 1 and in 
Model 2. Trunk FM, waist circumference, and waist-to-hip ratio were also 
positively correlated to BMC in all three subgroups. Together, these 
findings suggest that abdominal visceral fat has a positive effect on BMC in 
the Korean population. 
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Obesity and osteoporosis are significant public health problems 
with increasing prevalences and substantial economic burdens in most 
industrialized countries. In the United States of America (USA), in 2010, 
more than 10 million older adults had osteoporosis and the annual direct 
medical costs related to osteoporosis were estimated to be $17 to $20 
billion.1,2 In the same year, more than 35% of adults were obese. The total 
economic burden of obesity in the USA is estimated to increase by $50 to 
$60 billion per year by 2030.3,4 The prevalences of obesity and 
osteoporosis in Korea are similar: approximately 30% of adults are 
classified as obese and 13.1% of men and 24.3% of women aged 40 to 79 
years old are estimated to have osteoporosis.5,6 
   Obesity has a negative effect on most health conditions, especially 
cardiovascular and metabolic diseases, but obesity has been shown to 
reduce osteoporosis. Previous epidemiological studies have demonstrated 
a positive relationship between obesity parameters and bone mineral 
density (BMD).7-10 Several underlying mechanisms support this hypothesis: 
(1) the bone remodeling process is adaptive to increased weight bearing,11-
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13 (2) osteoclasts are suppressed by the adipocytes that produce 
estrogen,14,15 and (3) osteoblasts are activated by increased anabolic 
hormones such as insulin and insulin-like growth factor-I, which are related 
to obesity.16-18 However, obesity has not been conclusively determined to 
have a positive effect on osteoporosis. Most previous studies used 
anthropometric data such as body mass index (BMI) and waist 
circumference (WC) to assess obesity and these factors did not accurately 
reflect the quantity of fat. Also, recent data have demonstrated that different 
regional fats have different functions. Therefore, the exact relationship 
between fat and osteoporosis needs to be investigated.19-21 
Visceral obesity may offer new insight into the relationship between 
fat and osteoporosis due to its unique association with inflammation, which 
is also closely involved with bone metabolism.22-24 Recently, several reports 
have indicated that visceral obesity has a negative effect on bone mass,25,26 
but this association is controversial due to the difficulty in measuring 
visceral fat. The gold standard methods of measuring visceral fat are direct 
measures of fat volume using computed tomography (CT) or magnetic 
resonance imaging (MRI). However, these techniques have several 
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limitations including exposure to hazardous radiation and high costs. Dual 
energy x-ray absorptiometry (DXA) is widely used for measuring abdominal 
fat mass (FM) due to its relatively low cost and minimal radiation exposure, 
but it cannot distinguish visceral fat from abdominal subcutaneous fat. As 
stated, anthropometric measures such as WC and waist-to-hip ratio do not 
accurately measure fat quantity. 
In this study, we introduce epicardial fat thickness as a surrogate 
marker of visceral fat. We used this measurement, as well as 
anthropometric data and regional FM measured by DXA, to investigate the 
association between visceral obesity and bone mass. Epicardial fat located 
between the myocardium and the visceral pericardium has the same 
embryologic origin as intra-abdominal visceral fat. The use of transthoracic 
echocardiography to measure epicardial fat thickness is a simple and 






Study design and population 
The subjects included in this analysis were participants in the 
Healthy Twin Study, which was a nationwide population-based cohort study 
implemented as part of the Korean genome epidemiology study. It was 
initiated in 2005 and participants continue to receive follow-up examinations 
every 3 years. Participants consisted of a twin pair and their first degree 
family members. All participants received medical examinations and 
completed detailed questionnaires about life style and epidemiologic 
information at one of three medical school-affiliated hospitals. Details on 
the study design and protocols have been published previously.28  
Among the initial 1467 subjects who completed an echocardiogram 
and body composition measurements between 2006 and 2008, 269 
subjects were excluded: 220 subjects were excluded for poor 
echocardiographic image quality such as poor echo window or angle 
difference and 49 subjects were excluded for a treatment history of 
osteoporosis. A total of 1198 subjects (525 men, 460 premenopausal 
women, and 213 postmenopausal women) were included in our final 
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analysis. Women were considered to be postmenopausal if they had no 
history of menstruation during the previous year and fulfilled at least one of 
the following conditions: natural menopause, use of estrogen replacement 
therapy, or age older than 55 years. All participants provided written 
informed consent. The study protocol was approved by the Institutional 
Review Board at Seoul National University School of Public Health.  
 
Measurement of epicardial fat thickness 
Subjects underwent transthoracic echocardiogram according to 
standard techniques in the left lateral decubitus position using commercially 
available instruments (GE, USA). The images were recorded onto a digital 
database. The measurement of epicardial fat thickness was performed by 
two cardiologists using an offline DICOM (Digital imaging and 
Communications in Medicine) viewer (Onis 2.5 professional version). The 
cardiologists were unaware of the subjects’ clinical information. 
Epicardial fat thickness was identified as the echo-free space 
between the myocardium and the visceral epicardium, and its thickness 
was measured perpendicularly on the free wall of the right ventricle at end-
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systole from the standard parasternal long axis view.29 To standardize the 
measurements between observers, the aortic annulus was used as an 
anatomical landmark and the epicardial fat thickness was measured at the 
point on the free wall of the right ventricle along the midline of the 
ultrasound beam, perpendicular to the aortic annulus (Figure 1).30 The intra- 
and inter-observer agreement for the measurement of epicardial fat 
thickness were good and the intra-class correlation coefficients were 0.95 
(range, 0.93-0.97) and 0.92 (range, 0.88-0.95), respectively (Figure 2). 
 
Measurement of anthropometric data and body 
composition 
Body weight and height were measured according to standard 
methods while the subjects were wearing a light gown or light indoor 
clothing. Minimum WC was measured in the standing position at the point 
between the lower rib margin and the iliac crest. Hip circumference was 
measured as the largest circumference over the buttock. BMI was 
calculated as weight divided by height squared (kg/m2) and the waist-to-hip 
ratio was calculated as WC divided by hip circumference. Total bone 
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mineral content (BMC), bone mineral density (BMD) of the whole body, the 
lumbar spine, and the pelvis, whole-body and regional FM, and lean mass 
(LM) were measured using DXA (Delphi W, Hologic, Boston, MA, USA). 
Skeletal muscle mass (SM) was measured using a bioelectrical impedance 
analysis (BIA) meter (Biospace, Inbody720, Korea). The DXA and BIA 
equipment were calibrated by the manufacturer. The coefficients of 
variation for BMC, BMD, FM, LM, and SM measurements were < 1%. 
Percent FM was calculated as FM/(FM + LM + BMC) × 100.  
 
Clinical information  
The following clinical and demographic data were extracted from 
each patient’s baseline questionnaire: past medical history of chronic 
diseases including hypertension, diabetes mellitus, thyroid disease, and 
osteoporosis; female reproductive history including age at menopause and 
use of estrogen replacement therapy; and information about cigarette 






The value of each continuous variable is expressed as a mean ± 
standard deviation. Each categorical or discrete variable is presented as a 
percentage. Comparisons among the groups (men, premenopausal women, 
and postmenopausal women) were performed using analysis of variance 
(ANOVA), analysis of covariance (ANCOVA), and the chi squared (χ2) test. 
Multiple comparisons between two groups were performed with post hoc 
analysis. The relationships between the epicardial fat thickness and other 
measures of body composition were analyzed with Pearson’s correlation 
analysis. Two multiple linear regression models in each group were used to 
evaluate associations between visceral obesity and bone mass; age and 
height were included as covariates in regression Model 1 and past medical 
history (hypertension, diabetes mellitus, and thyroid disease), and smoking, 
alcohol, and exercise habits were added as covariates in Model 2. We also 
evaluated associations between BMC and body composition variables 
using a linear mixed model to correct for familiar interdependence. Age, 
height, hypertension, diabetes, hyperthyroid disease, smoking habits, 
alcohol consumption, and regular exercise were adjusted as fixed effects, 
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and family unit was adjusted as a random effect. Statistical analyses were 
performed using SPSS 18.0 for Windows (Chicago, IL, USA). All tests were 






The baseline characteristics of the subjects are listed in Table 1. 
The body composition parameters and clinical information are statistically 
different according to gender and menopausal status. Men had higher BMI, 
WC, waist-to-hip ratio, LM, and SM than women. Fat-related parameters 
such as FM and trunk FM were lower in men than in women, with the 
exception of head FM. Postmenopausal women had more total fat and 
trunk fat, but had lower leg fat, LM, and SM than premenopausal women. 
Epicardial fat thickness was highest in postmenopausal women and lowest 
in premenopausal women. BMC was higher in men due to their larger body 
size compared with women. However, the difference in BMD between the 
genders was small and no significant difference in spine BMD was 
identified between men and premenopausal women. Hypertension and 
diabetes mellitus were most prevalent in postmenopausal women; risky 
heath behaviors such as smoking and drinking alcohol were highest in men.  
Figure 3 and Table 2 show the correlations of epicardial fat 
thickness with anthropometric and body composition variables. Epicardial 
fat thickness was highly associated with body FM, especially trunk FM in 
11 
 
postmenopausal women. Epicardial fat thickness was also associated with 
classical central obesity parameters such as WC and waist-to-hip ratio. 
Epicardial fat was positively correlated with age, but BMC was negatively 
correlated with age. BMC showed a strong positive correlation with height.   
  
We also examined the difference in whole-body BMC, whole-body 
BMD, and body-part specific BMD across the tertiles of epicardial fat 
thickness, adjusting for age and height in all three subgroups using the 
ANCOVA test. As shown in Table 3, BMC significantly increased across 
increasing tertiles of epicardial fat thickness in all subgroups. This tendency 
was not observed in whole-body or spine BMD, particularly in women.  
Figure 4 shows the association between BMC and epicardial fat 
thickness and trunk fat. In bivariate unadjusted analyses, BMC increased 
with increasing epicardial fat thickness in all subgroups. These tendencies 
were also observed in associations between BMC and trunk fat in the 
subgroups.  
Table 4 shows the multivariable adjusted associations between 
BMC and body composition variables. Epicardial fat thickness was 
12 
 
positively associated with BMC in men, premenopausal women, and 
postmenopausal women in the age- and height-adjusted model (Model 1). 
The association was unchanged after controlling for past medical history 
(hypertension, diabetes, and hyperthyroid disease) and behavioral factors 
(smoking, alcohol, and exercise habits; Model 2). Trunk FM and classical 
indices of abdominal obesity parameters such as WC and waist-to-hip ratio 
were also positively associated with BMC in both models. The same 
associations were observed with total FM. After correcting for familial 
interdependence using a linear mixed model, the association between 
abdominal fat and BMC was still positive (Table 5). 
Approximately 15% of the initial subjects were excluded from 
analysis due to poor echocardiographic images that affected measurement 
reliability (Supplemental Figure 1). These subjects were younger and had 
lower total fat and abdominal fat, including epicardial fat thickness, than the 
subjects with good echocardiographic images (Supplemental Table 1). The 
associations between BMC and abdominal fat did not change when 
subjects with poor echocardiographic images were included in the analysis. 
The β coefficient of the association between epicardial fat and BMC in 
13 
 
Model 2 was 0.117 for men (SE: ± 0.020, p-value = 0.000), 0.076 for 
premenopausal women (SE: ± 0.020, p-value = 0.000), and 0.065 for 





The results from our study of the Korean Healthy Twin cohort 
showed that visceral fat estimated from epicardial fat thickness was 
positively associated with BMC regardless of gender and menopausal 
status. Its relationship was also evident with other abdominal obesity 
parameters such as WC, waist-to-hip ratio, and trunk fat.  
The exact association between fat and bone is still controversial, but 
this relationship has long been an interesting research topic among 
epidemiologists. Several previous studies reported positive associations 
between fat and BMC or BMD and two plausible mechanisms have been 
suggested on the basis of two main characteristics of fat.31 One mechanism 
is related to increased weight bearing of bones, which directly activates 
adaptive bone remodeling; 11-13 the other mechanism is associated with 
paracrine and hormonal effects of fat, which enhance anabolic effects on 
bone through increased production of sex hormones and hormonal factors 
such as insulin, leptin, and amylin.14-18 However, other previous reports 
demonstrated a negative relationship between fat and BMC or BMD.9,32-34 
In most of these studies, body weight was used as an important covariate 
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in the analysis, but this may cause a false association between FM and 
bone mass due to biases from strong co-linearity between FM and body 
weight.35 On the basis of this methodology, we did not use body weight as 
a covariate for investigating influences of fat on bone mass and BMD. 
Instead of weight, we used height as an important covariate because 
whole-body BMC and BMD are highly associated with whole-body bone 
size, and height is known to be a good surrogate marker for body and bone 
size .31,32 
Abdominal visceral fat has unique characteristics compared with 
other fat such as subcutaneous fat.26,36 Therefore, a simple and accurate 
method for measuring abdominal visceral fat is necessary to investigate the 
exact association between abdominal visceral fat and bone mass. Although 
CT and MRI are gold standard methods of measuring visceral fat, they 
present challenges for use in a large study due to exposure to hazardous 
radiation and high costs. Therefore, DXA is the most widely used technique 
for measuring abdominal fat. Still, its weakness is the inability to 
differentiate visceral fat from subcutaneous fat. In this study, we introduced 
epicardial fat thickness as a surrogate measure of visceral fat for the first 
16 
 
time to evaluate the association between visceral fat and bone mass. 
Epicardial fat is widely used in studies of diseases related to metabolic 
syndrome and atherosclerosis and it is known to have the same 
embryologic origin as intra-abdominal visceral fat. Epicardial fat thickness 
measured by transthoracic echocardiography has been highly associated 
with abdominal visceral fat quantity measured by MRI.27 According to our 
study results, visceral fat estimated from epicardial fat and total FM are 
positively associated with BMC. The reason for the positive association 
between BMC and abdominal visceral fat was not evaluated in this study. 
The systemic effects of visceral fat such as hyperinsulinemia due to insulin 
resistance and altered sex hormone metabolism might be important factors 
and should be evaluated in future studies.35,37  
BMD has been widely used as a surrogate marker for the diagnosis 
of osteoporosis and osteopenia, but, in this study, we used BMC as a 
surrogate and dependable variable for bone mass. BMD measured with 
DXA reflects areal BMD rather than volumetric BMD, and it likely 
overestimates and underestimates BMD for subjects who are larger and 
smaller than average size people, respectively.38 Bone area is a major 
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component for calculating BMD and it is highly correlated with body size 
and FM. These limitations remove the association between fat and bone 
mass, so, in this study, we used BMC to study the associations between 
bone mass and body composition parameters. 
This study has several strengths. Principally, it is the first study to 
demonstrate an association between visceral fat estimated from epicardial 
fat and bone mass. Also, we used diverse methods for estimating 
abdominal fat and considered a wide range of probable covariates that 
influence BMC, which allowed us to achieve an accurate estimation of the 
association between abdominal visceral fat and BMC. However, this study 
has several limitations. This study was a cross-sectional design and all 
participants were Korean. Therefore, it is impossible to establish causal 
relationships or generalize the findings to other ethnicities. Further, 
echocardiographic epicardial fat thickness may not reflect the exact 
quantity of total epicardial fat because it is a linear measurement and varies 
at different locations around the myocardium. In the future, large 
longitudinal studies that measure volumetric visceral fat will reveal the 
relationship between abdominal visceral fat and bone.  
18 
 
In conclusion, this study showed that abdominal visceral fat 
estimated from epicardial fat thickness was positively associated with BMC. 
These findings suggest that visceral fat has a protective effect on bone 
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Figure 1. Measurement of epicardial fat thickness
Epicardial fat thickness was measured perpendicularly on the free wall of right ventricle
from parasternal long axis view at end-systole.
Abbreviation : RV - right ventricle, LV - left ventricle, LA - left atrium
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A
Intra-class correlation coefficient : 0.95
B
Intra-class correlation coefficient : 0.92
Figure 2. 
The intra- and inter-observer agreement for epicardial fat thickness was expressed as  Bland-Altman















Figure 3.  Correlogram of epicardial fat with anthopometric and  body composition variables
Abbreviation)
Epifat – epicardial fat thickness, BMC – bone mineral content, BMI – body mass index, 
WC – waist circumference, WHR – waist to hip ratio
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Figure 4. 
Association between BMC and epicardial fat thickness or trunk fat.




β coeff = 0.115, p = 0.043 β coeff = 0.370, p = 0.000
β coeff = 0.369, p = 0.000 β coeff = 0.549, p = 0.000
β coeff = 0.377, p = 0.000 β coeff = 0.527, p = 0.000
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A
Intra-class correlation coefficient : 0.77
B
Intra-class correlation coefficient : 0.63
Supplement figure 1. 
The intra- and inter-observer agreement for epicardial fat thickness of excluded subjects due to poor 




Table 1. Baseline characteristics of study population 
Data are expressed as means ± SD. 
Post hoc analysis by independent t-test (mean difference between two groups):  
a: men vs. premenopausal women; b: men vs. postmenopausal women; c: premenopausal vs. 
postmenopausal women. 
Discrete variables were analyzed by the χ2 test.  
P < 0.05 was considered significant. 
















Age (years) 44.2 ± 14.7 35.5 ± 8.4 56.2 ± 8.1 43.0 ± 13. a,b,c 
Epicardial fat  
thickness (mm) 
1.93 ± 0.72 1.73 ± 0.72 2.17 ± 0.81 1.90 ± 0.75 a,b,c 
BMC_whole body (kg) 2.51 ± 0.40 2.04 ± 0.33 1.80 ± 0.31 2.21 ± 0.46 a,b,c 
BMD_whole (g/cm2) 1.17 ± 0.13 1.11 ± 0.19 1.03 ± 0.12 1.13 ± 0.16 a,b,c 
BMD_spine (g/cm2) 0.98 ± 0.17 0.98 ± 0.13 0.88 ± 0.19 0.96 ± 0.16 b,c 
BMD_pelvis (g/cm2) 1.15 ± 0.16 1.11 ± 0.13 1.06 ± 0.20 1.12 ± 0.16 a,b,c 
Height (cm) 170.2 ± 8.5 158.2 ± 9.5 155.2 ± 5.4 162.9 ± 11 a,b,c 
Weight (Kg) 71.6 ± 10.5 57.2 ± 9.2 58.4 ± 8.5 63.7 ± 11.9 a,b 
BMI (Kg/m2) 24.5 ± 2.9 22.6 ± 3.2 24.2 ± 3.1 23.7 ± 3.2 a,c 
Waist  
circumference (cm) 
85.7 ± 7.9 76.1 ± 8.2 81.7 ± 8.4 81.3 ± 9.2 a,b,c 
Waist to hip ratio 0.91 ± 0.21 0.84 ± 0.06 0.90 ± 0.06 0.88 ± 0.16 a,c 
Fat mass (kg) 16.0 ± 5.4 17.9 ± 5.4 19.8 ± 5.1 17.4 ± 5.5 a,b,c 
Percent fat mass (%) 22.5 ± 5.4 31.4 ± 6.1 34.4 ± 5.0 28.0 ± 7.5 a,b,c 
Trunk fat mass (kg) 8.7 ± 3.3 8.5 ± 3.3 10.5 ± 3.2 9.0 ± 3.4 b,c 
Percent trunk  
fat mass (%) 
25.0 ± 6.6 30.6 ± 7.5 35.6 ± 6.3 29.0 ± 8.0 a,b,c 
Head fat mass (kg) 1.2 ± 0.2 1.0 ± 1.1 1.0 ± 0.1 1.1 ± 0.7 a,b 
Leg fat mass (kg) 4.4 ± 1.6 6.3 ± 1.7 5.8 ± 1.6 5.4 ± 1.9 a,b,c 
Soft lean mass (kg) 52.4 ± 6.6 37.2 ± 4.7 36.0 ± 3.9 44.4 ± 9.6 a,b 
Skeletal muscle  
mass (kg) 
31.0 ± 4.3 21.3 ± 2.9 20.5 ± 2.4 25.9 ± 6.2 a,b 
Hypertension (%) 17.0 2.6 27.7 13.4 a,b,c 
Diabetes mellitus (%) 6.9 1.1 8.5 4.9 a,c 
Hyperthyroidism (%) 0.6 2.6 0.9 1.4 a 
Smokers (%) 67.4 12.8 5.2 35.7 a,b,c 
Drinkers (%) 85.0 74.8 45.1 74.3 a,b,c 
Regular exercise (%) 41.7 30 40.8 37.7 a,c 
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Fat mass 0.368*** 0.392*** 0.484*** 0.392*** 
Trunk fat mass 0.375*** 0.388*** 0.495*** 0.423*** 
Arms fat mass 0.341*** 0.336*** 0.407*** 0.340*** 
Legs fat mass 0.262*** 0.301*** 0.340*** 0.220*** 
Head fat mass 0.241*** -0.037 0.274*** 0.009 
Height 0.008 0.069 -0.060 0.023 
Weight 0.361*** 0.393*** 0.470*** 0.338*** 
Waist 0.469*** 0.393*** 0.496*** 0.444*** 
Hip 0.298*** 0.317*** 0.444*** 0.326*** 
BMI 0.473*** 0.437*** 0.553*** 0.519*** 
Waist to hip ratio 0.058 0.390*** 0.611*** 0.163*** 
Soft lean mass 0.136* 0.401*** 0.418*** 0.204*** 
Skeletal muscle mass 0.126* 0.400*** 0.405*** 0.197*** 
Data presented are Pearson correlation coefficients. 
*P<0.05; **P<0.01; ***P<0.001 




Table 3. Comparisons of the least squares means of bone mineral content 
(BMC) and bone mineral density (BMD) according to epicardial fat 
thickness tertiles adjusted for age and height  
 
 Epicardial fat thickness 
p for trend P-value 
 1st tertile 2nd tertile 3rd tertile 
Men      
BMC_whole (kg) 2.42 ± 0.03 2.51 ± 0.03 2.61 ± 0.03 0.000 a,b,c 
BMD_whole (g/cm2) 1.16 ± 0.01 1.17 ± 0.01 1.19 ± 0.01 0.048 b 
BMD_spine (g/cm2) 0.98 ± 0.01 0.98 ± 0.01 0.98 ± 0.01 0.978 - 
BMD_pelvis (g/cm2) 1.12 ± 0.01 1.14 ± 0.01 1.18 ± 0.01 0.024 b,c 
      
Premenopausal women      
BMC_whole (kg) 2.02 ± 0.02 2.01 ± 0.03 2.11 ± 0.03 0.029 b,c 
BMD_whole (g/cm2) 1.11 ± 0.01 1.10 ± 0.01 1.13 ± 0.02 0.085 c 
BMD_spine (g/cm2) 0.98 ± 0.01 0.97 ± 0.01 0.99 ± 0.01 0.397 - 
BMD_pelvis (g/cm2) 1.09 ± 0.01 1.10 ± 0.01 1.14 ± 0.01 0.032 b,c 
      
Postmenopausal women      
BMC_whole (kg) 1.72 ± 0.04 1.77 ± 0.03 1.87 ± 0.03 0.003 b,c 
BMD_whole (g/cm2) 1.01 ± 0.02 1.02 ± 0.01 1.05 ± 0.01 0.063 b 
BMD_spine (g/cm2) 0.84 ± 0.03 0.87 ± 0.02 0.91 ± 0.02 0.104 b 
BMD_pelvis (g/cm2) 1.05 ± 0.03 1.03 ± 0.03 1.08 ± 0.02 0.014 a,b,c 
      
Total      
BMC_whole (kg) 2.15 ± 0.02 2.20 ± 0.02 2.28 ± 0.02 0.000 a,b,c 
BMD_whole (g/cm2) 1.11 ± 0.01 1.12 ± 0.01 1.15 ± 0.01 0.000 b,c 
BMD_spine (g/cm2) 0.96 ± 0.01 0.95 ± 00 0.97 ± 0.01 0.000 - 
BMD_pelvis (g/cm2) 1.09 ± 0.01 1.11 ± 0.01 1.15 ± 0.01 0.000 b,c 
Data are expressed as means ± standard error of the mean. 
Post hoc analysis using the least significant difference t-test (mean difference between two groups):  






Table 4. Gender-specific associations between bone mineral content and epicardial fat thickness and body composition variables 
by multiple linear regression analyses 
SE: standard errors 
Model 1: Covariates included in the regression model were age and height. 
Model 2: Model 1 + additional adjustments for hypertension, diabetes, hyperthyroid disease, smoking habits, alcohol consumption, and regular exercise. 
 
  
 Men Premenopausal women Postmenopausal women Total 
 β ± SE P-value β ± SE P-value β ± SE P-value β ± SE P-value 
Model 1         
Epicardial fat thickness 0.115 ± 0.021 0.000 0.069 ± 0.021 0.001 0.080 ± 0.023 0.001 0.083 ± 0.013 0.000 
Waist to hip ratio 3.178 ± 0.465 0.000 1.027 ± 0.313 0.001 1.964 ± 0.528 0.000 2.033 ± 0.248 0.000 
Trunk fat mass 0.020 ± 0.005 0.000 0.024 ± 0.004 0.000 0.032 ± 0.006 0.000 0.017 ± 0.003 0.000 
Total fat mass 0.013 ± 0.003 0.000 0.015 ± 0.003 0.000 0.022 ± 0.004 0.000 0.009 ± 0.002 0.000 
Soft lean mass 0.044 ± 0.003 0.000 0.046 ± 0.004 0.000 0.047 ± 0.008 0.000 0.040 ± 0.002 0.000 
         
Model 2         
Epicardial fat thickness 0.119 ± 0.023 0.000 0.069 ± 0.023 0.003 0.076 ± 0.024 0.002 0.086 ± 0.014 0.000 
Waist to hip ratio 3.843 ± 0.530 0.000 2.228 ± 0.381 0.000 1.939 ± 0.605 0.002 2.799 ± 0.283 0.000 
Trunk fat mass 0.022 ± 0.005 0.000 0.023 ± 0.005 0.000 0.031 ± 0.006 0.000 0.019 ± 0.003 0.000 
Total fat mass 0.015 ± 0.003 0.000 0.015 ± 0.003 0.000 0.021 ± 0.004 0.000 0.011 ± 0.002 0.000 
Soft lean mass 0.046 ± 0.004 0.000 0.045 ± 0.004 0.000 0.047 ± 0.009 0.000 0.041 ± 0.002 0.000 
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Table 5. Multivariable adjusted associations between bone mineral content and body composition variables using a linear mixed 
model 
SE: standard errors 
The fixed effects (age, height, hypertension, diabetes, hyperthyroid disease, smoking habits, alcohol consumption, and regular exercise) and the random effect (family unit) were 
adjusted. 
  
 Men Premenopausal women Postmenopausal women Total 
 β ± SE P-value β ± SE P-value β ± SE P-value β ± SE P-value 
Epicardial fat thickness 0.107 ± 0.021 0.000 0.076 ± 0.022 0.001 0.058 ± 0.020 0.004 0.070 ± 0.013 0.000 
Waist to hip ratio 3.760 ± 0.514 0.000 1.772 ± 0.473 0.000 2.200 ± 0.514 0.000 2.724 ± 0.293 0.000 
Trunk fat mass 0.030 ± 0.005 0.000 0.027 ± 0.005 0.000 0.030 ± 0.005 0.000 0.021 ± 0.003 0.000 
Total fat mass 0.020 ± 0.003 0.000 0.017 ± 0.003 0.000 0.020 ± 0.003 0.000 0.012 ± 0.002 0.000 
Soft lean mass 0.045 ± 0.004 0.000 0.051 ± 0.005 0.000 0.049 ± 0.008 0.000 0.043 ± 0.003 0.000 
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Supplemental Table 1. Baseline characteristics of the study population 
according to echocardiographic image quality  
Data are expressed as means ± SD. 
Discrete variables were analyzed by the χ2 test.  



























Epicardial fat thickness (mm) 1.90 ± 0.75 1.46 ± 0.67 0.000 
BMC_whole body (kg) 2.21 ± 0.46 2.24 ± 0.46 0.161 
Height (cm) 162.9 ± 10.7 164.4 ± 8.7 0.052 
Weight (Kg) 63.7 ± 11.9 61.9 ± 12.3 0.039 
BMI (Kg/m2) 23.7 ± 3.2 22.9 ± 3.5 0.011 
Waist circumference (cm) 81.3 ± 9.2 78.4 ± 9.8 0.000 
Waist to hip ratio 0.88 ± 0.16 0.85 ± 0.06 0.039 
Fat mass (kg) 17.4 ± 5.5 15.5 ± 5.6 0.000 
Trunk fat mass (kg) 9.0 ± 3.4  7.7 ± 3.4  0.000 
Head fat mass (kg) 1.1 ± 0.7 1.0 ± 0.2 0.436 
Soft lean mass (kg) 44.4 ± 9.6 44.5 ± 10.2 0.940 
Skeletal muscle mass (kg) 25.9 ± 6.2 26.1 ± 6.6 0.853 
Hypertension (%) 13.4 7.2 0.035 
Diabetes mellitus (%) 4.9 4.3 0.545 
Hyperthyroidism (%) 1.4 2.4 0.310 
Smokers (%) 35.7 36.1 0.901 
Drinkers (%) 74.3 77.4 0.387 






심외막지방 측정을 통한 복부 내장






복부내장지방이 심혈관계 및 대사성질환에 부정적인 영향을 주는 것으
로 잘 알려져 있지만, 복부내장지방과 골다공증과의 관계는 아직 정립되
어 있지 않다. 이번 연구에서는 경흉부심초음파를 이용해 측정한 심외막
지방(epicardial fat)과 이중에너지 방사선흡수법(dual energy x-ray 
absorptiometry, DXA)을 통해 측정한 골무기질량(bone mineral content, 
BMC)의 연관성 분석을 통해 복부지방과 골다공증간의 관계를 밝혀보고
자 하였다. 연구대상은 총 1198명 (남자 525명, 폐경전여성 460명, 폐경 
후 여성 213명)으로 한국형 쌍둥이 코호트연구(The Healthy Twin study)
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에서 선정되었다. 심외막지방은 경흉부심초음파의 흉골연 장축단면도
(parasternal long axis view)에서 수축말기의 우심실 심근과 장측 심낭막
(visceral pericardium) 사이의 지방의 두께로 측정되었다. 전체 지방량, 
부위별 지방량 및 제지방체중(lean body mass) 및 골무기질량은 DXA 방
법으로 측정되었다. 연령 및 키를 보정한 다중선형회귀분석에서 복부내
장 지방의 대체 측정치인 심외막지방의 두께는 남자, 여자 모두에서 골
무기질량과 양의 상관관계를 보였다. 또한 과거질병력과 흡연력, 음주력, 
규칙적인 운동상태 등을 추가 보정한 모델에서도 심외막지방과 골무기질
량의 관계는 양의 상관관계로 나타났다. 이와 같은 연관성은 다른 방법
(waist circumference, Waist to hip ratio, trunk fat from DXA) 으로 측정된 
복부지방지표와 골무기질량간의 연관성 분석에서 그대로 나타났다. 이러
한 결과는 복부내장지방이 심혈관 질환 및 대상성 질환에 부정적인 영향
을 주는 것에 비해, 골무기질량에는 긍정적인 영향을 미칠 가능성을 보
여준다.   
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